Form 4 for NVCT Nuvectis Pharma, Inc.
Accepted 2023-06-16 00:00:00 ET · period of report 2023-06-15 · accession 0001104659-23-071869 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-06-16 | 2023-06-15 | NVCT | Mosseri Marlio Charles | 10% | P - Purchase | $17.71 | +32.1K | 2.41M | +1% | +$568.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-06-15 | P | A | 400 | $17.54 | 2,380,576 | D | — | — | |
| 2 | Common | Common Stock | 2023-06-15 | P | A | 31,724 | $17.71 | 2,412,300 | D | — | — |